Providence Capital Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
Sell
-130
Closed -$4K 325
2018
Q4
$4K Hold
130
﹤0.01% 227
2018
Q3
$7K Hold
130
﹤0.01% 216
2018
Q2
$8K Hold
130
0.01% 199
2018
Q1
$6K Hold
130
﹤0.01% 214
2017
Q4
$5K Buy
+130
New +$5K ﹤0.01% 265